Four-point Peritoneal Flap Fixation in Preventing Lymphocele Formation Following Radical Prostatectomy

Stolzenburg, Jens‐Uwe; Arthanareeswaran, Vinodh Kumar Adithyaa; Dietel, Anja; Franz, Toni; Liatsikos, Evangelos; Kyriazis, Iason; Ganzer, Roman; Yaney, Krassimir; Minh, Hoang

doi:10.1016/j.euo.2018.03.004

Cited by 42 publications

(51 citation statements)

References 14 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Postoperative lymphoceles are the most common complication of pelvic lymph node dissection and at times associated with considerable morbidity. Recently, two working groups evaluating a modification of the surgical technique-the creation of a peritoneal flap-have reported positive effects on the postoperative lymphocele rate (16,17). Our external validation by means of a multicenter, randomized, controlled study with blinded assessment of the study endpoint provided evidence in support of the following points:…”

Section: Discussionmentioning

confidence: 54%

“…Since adverse events or changes in early functional or oncological criteria were not observed with this modification, the authors recommended this surgical modification as safe, effective and feasible for broad adoption in daily clinical routine (16). Even though other working groups have published confirmatory results from their peritoneal flap studies, this modification has not yet been validated by direct evidence from studies with a prospective controlled design (17).…”

mentioning

confidence: 99%

See 1 more Smart Citation

Peritoneal Flap in Robot-Assisted Radical Prostatectomy

Bründl¹,

Lenart²,

Stojanoski³

et al. 2020

Deutsches Ärzteblatt International

View full text Add to dashboard Cite

ith almost 61 000 new cases per year, prostate cancer (PCa) is the most common male cancer in Germany (1, 2). Of the potentially curative treatment options, radical prostatectomy with concomitant pelvic lymph node dissection (PLND) is the most commonly chosen surgical procedure (3-5). On the one hand, PLND remains the most accurate staging procedure for the detection of lymphatic metastasis and, on the other hand, the decision on which consecutive treatment should SummaryBackground: Lymphocele is the most common complication arising after pelvic lymph node dissection (PLND) in the setting of robot-assisted radical prostatectomy (RARP). The only data available until now on the utility of a peritoneal flap to prevent lymphocele were retrospectively acquired.Methods: A randomized, controlled, multi-center trial with blinded assessment of endpoints was carried out on 232 patients with prostate cancer who underwent RARP with PLND. The patients in the intervention group were given a peritoneal flap; in the control group, surgery was performed without this modification. The two joint primary endpoints were the rates of symptomatic lymphocele during the same hospitalization as the operative procedure (iT1) and within 90 days of surgery (iT2). The secondary endpoints were lymphocele volume, the need for treatment of lymphocele, complications requiring an intervention, and the degree of postoperative stress incontinence. German Clinical Trials Register number: DRKS00011115.Results: The data were evaluated in an intention-to-treat analysis, which, in this trial, was identical to an as-treated analysis. 108 patients (46.6%) were allotted to the intervention group. There were no statistically significant intergroup differences with respect to any clinical or histopathological criteria. A median of 16 lymph nodes were removed (interquartile range, 11-21). A symptomatic lymphocele arose in 1.3% (iT1) and 9.1% (iT2) of the patients, without any statistically significant difference between the two trial groups (p = 0.599 and p = 0.820, respectively). Nor did the groups differ significantly with respect to lymphocele volume (p = 0.670 on hospital discharge [T1], p = 0.650 90 days after surgery [T2]) or the type and frequency of need for subsequent surgical intervention (p = 0.535; iT2). 81.5% of all patients (n = 189) had no complications at all in the first three months after surgery. Nor were there any intergroup differences at 90 days with respect to the degree of stress urinary incontinence (p = 0.306) or complications (p = 0.486).Conclusion: A peritoneal flap after RARP was not found to influence the rate of postoperative lymphocele, whether asymptomatic or requiring treatment.

show abstract

Section: Discussionmentioning

confidence: 54%

mentioning

confidence: 99%

Peritoneal Flap in Robot-Assisted Radical Prostatectomy

Bründl¹,

Lenart²,

Stojanoski³

et al. 2020

Deutsches Ärzteblatt International

View full text Add to dashboard Cite

show abstract

“…Finally, a surgical modification using a peritoneal flap was suggested to potentially reduce LC formation [32, 33]. The prospective randomized PIANOFORTE trial recently published by our group, however, did not show an influence on post-operative LC rates [21].…”

Section: Discussionmentioning

confidence: 99%

High BMI, Aggressive Tumours and Long Console Time Are Independent Predictive Factors for Symptomatic Lymphocele Formation after Robot-Assisted Radical Prostatectomy and Pelvic Lymph Node Dissection

et al. 2021

View full text Add to dashboard Cite

Introduction: Lymphocele (LC) formation is a common complication which may cause severe symptoms after robot-assisted radical prostatovesiculectomy (RARP) with concomitant pelvic lymph node dissection (PLND). Compared to open radical prostatectomy, the amount of data on potential risk factors for LC formation is still limited. The aim of the present study was to identify risk factors for symptomatic LC formation (sLC) after RARP with PLND. Methods: We used the data of a prospective multicentre series of 232 RARP patients which were treated between March 2017 and December 2017. The primary endpoint was the presence of sLC within 90 days. Asymptomatic LC (aLC) formation was also recorded. We evaluated clinical, perioperative, and histopathological criteria and compared their distribution in patients with and without post-operative sLC. Uni- and multivariable logistic regression analyses (MVAs) were performed to identify potential predictors for LC formation. Regarding the influence of patients’ BMI, 2 models were calculated: BMI continuously (model 1) and BMI dichotomized with cut-off 30 kg/m2 (WHO definition, model 2). Results: Post-operative sLC was present in 21 patients (9.1%), while aLC was detected in 49 patients (21.1%) 90 days after RARP with PLND. Patients with sLC showed higher median baseline PSA levels (9.8 vs. 8.1 ng/mL), higher prevalence of obesity (BMI >30; 42.9 vs. 19.9%), and longer median console time (180 vs. 165 min) compared to patients without sLC. On MVA higher BMI {model 1: OR 1.145 (confidence interval [CI] 1.025–1.278); model 2: OR 2.761 (1.045–7.296)}, longer console time (model 1: OR 1.013 [1.005–1.021]; model 2: OR 1.013 [1.005–1.020]) and an ISUP grade ≥3 (model 1: OR 3.247 [1.182–8.917]; model 2: OR 2.791 [1.050–7.423]) were identified as independent predictors for sLC development. Conclusion: Patients with aggressive tumours and higher BMI should be informed about a potentially increased risk for sLC formation. In case of a long console time, a close and regular follow-up should be considered to check for LC development.

show abstract

“…Given the increasing need of performing extended PLNDs the most promising, low-quality, evidence comes from techniques that enhance the peritoneal surface of reabsorption. The techniques described in the setting of extraperitoneal [32] or transperitoneal [33,22,34] approaches are cheap, safe and quick, however, evidence from randomized clinical trials is awaited to confirm these results.…”

Section: Discussionmentioning

confidence: 99%